Abstract
AbstractAlthough sex, genetics, and exposures can individually influence risk for sporadic Parkinson’s disease (PD), the joint contributions of these factors to the epigenetic etiology of PD have not been comprehensively assessed. Here, we profiled sex-stratified genome-wide blood DNAm patterns, SNP genotype, and pesticide exposure in agricultural workers (71 early-stage PD cases, 147 controls) and explored replication in three independent samples of varying demographics (n = 218, 222, and 872). Using a region-based approach, we found more associations of blood DNAm with PD in females (69 regions) than in males (2 regions, Δβadj| ≥0.03, padj ≤ 0.05). For 48 regions in females, models including genotype or genotype and pesticide exposure substantially improved in explaining interindividual variation in DNAm (padj ≤ 0.05), and accounting for these variables decreased the estimated effect of PD on DNAm. The results suggested that genotype, and to a lesser degree, genotype-exposure interactions contributed to variation in PD-associated DNAm. Our findings should be further explored in larger study populations and in experimental systems, preferably with precise measures of exposure.
Funder
Gouvernement du Canada | Canadian Institutes of Health Research
Canadian HIV Trials Network, Canadian Institutes of Health Research
Bundesministerium für Bildung und Forschung
Agence Nationale de la Recherche
Agence Nationale de Sécurité du Médicament et des Produits de Santé
EU Joint Programme – Neurodegenerative Disease Research
Publisher
Springer Science and Business Media LLC
Reference119 articles.
1. Maserejian, N., Vinikoor-Imler, L. & Dilley, A. Estimation of the 2020 global population of Parkinson’s Disease (PD). MDS Abstracts. https://www.mdsabstracts.org/abstract/estimation-of-the-2020-global-population-of-parkinsons-disease-pd/ (2020).
2. Feigin, V. L. et al. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 16, 877–897 (2017).
3. Villar-Piqué, A., Lopes da Fonseca, T. & Outeiro, T. F. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. J. Neurochem. 139, 240–255 (2016).
4. Jensen, M. P. et al. Lower lymphocyte count is associated with increased risk of Parkinson’s disease. Ann. Neurol. 89, 803–812 (2021).
5. Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression, and mortality. Neurology 17, 427–427 (1967).